ENSAYO PARA LA DETERMINACIÓN DE ANTICUERPOS IGG FRENTE AL SARS-COV-2. - COFEPRIS Registration 1402R2024 SSA
Access comprehensive regulatory information for ENSAYO PARA LA DETERMINACIÓN DE ANTICUERPOS IGG FRENTE AL SARS-COV-2. (ENSAYO PARA LA DETERMINACIÓN DE ANTICUERPOS IGG FRENTE AL SARS-COV-2.) in the Mexico medical device market through Pure Global AI's free database. This Clase II medical device is registered under COFEPRIS analysis ID 1402R2024 SSA and manufactured by ABBOTT LABORATORIES DE MÉXICO, S.A. DE C.V.. The device was registered on May 15, 2024.
This page provides complete registration details including product type (III. Agentes de diagnóstico), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.

